Enterprise Diagnostics
Regulation Crowdfunding offering on Wefunder
$58,379
of $124,000 goal
47.1% funded
About the offering
Enterprise Diagnostics is building an operational intelligence platform for middle-market private equity portfolio companies, leveraging Palantir Foundry to deliver Fortune 500-level AI capabilities to companies with $50M-$500M in revenue. The company's core offering is a 60-day paid diagnostic that creates a digital twin of the enterprise, integrating disparate data streams to identify hidden friction between customers, products, and revenue—followed by ongoing subscription-based intelligence monitoring.The ProblemMiddle-market private equity firms manage over $2 trillion in assets across thousands of portfolio companies operating on 3-5 year exit timelines. These companies compete against larger rivals with access to enterprise-grade operational intelligence, but have been locked out of platforms like Palantir Foundry due to cost and complexity. PE firms increasingly need operational value creation rather than financial engineering alone to drive exits, but traditional consulting takes 3-6 months, internal analysis projects take 6-12 months, and point solutions like BI tools and dashboards are insufficient for complex operational challenges. The result is that portfolio companies lack the unified data intelligence needed to identify and act on EBITDA improvement opportunities before their exit window closes.The SolutionEnterprise Diagnostics delivers a 60-day diagnostic engagement that builds a high-fidelity digital twin of the client's enterprise on Palantir Foundry. The platform integrates fragmented data sources across organizational silos into a unified ontology with embedded predictive AI, moving from raw data to actionable "Execution Intelligence" in 30-60 days. The diagnostic identifies opportunities and delivers validated roadmaps with quick wins, medium-range plays, and strategic bets. The platform then becomes an always-on intelligence layer that monitors metrics in real time, predicts outcomes, and alerts leaders to emerging opportunities and risks. The company describes its diagnostic frameworks as 70-80% reusable across similar companies, enabling rapid deployment across PE portfolios.Business ModelThe model operates as a land-and-expand within PE ecosystems. The entry point is a $100K diagnostic (60-day engagement). The company projects 50% conversion from diagnostics to annual platform subscriptions, creating sticky recurring revenue with high switching costs once embedded in operations. The PE flywheel drives acquisition efficiency: one Operating Partner relationship yields 5-10 portfolio companies, and successful deployments become reference cases for other PE firms. Cross-portfolio benchmarking creates additional value and lock-in. The company has a locked 2-year Palantir Foundry partnership at $300K annually, providing platform stability and pricing power. Projected unit economics include a 96:1 LTV to CAC ratio and 70%+ gross margins at scale.TractionThe company has collaborated with 10+ PE Operating Partners to validate diagnostic frameworks before building the product. The Syndicate Lead (Ben Cody, $50,000 investment) is an Enterprise Software Product Executive with 33 years of experience who states he has "seen no other offering in the market that can match what Enterprise Diagnostics is doing." The company has a locked 2-year Palantir partnership through the Palantir for Builders program. No completed diagnostics, paying customers, or revenue were disclosed—the company appears to be pre-revenue with validated frameworks but no commercial deployments.Market OpportunityThe company estimates a $12B+ TAM targeting 200+ PE firms managing 5,000+ portfolio companies. PE dry powder is at record highs ($2.5T+), exit multiples are increasingly tied to operational metrics rather than just revenue growth, and AI adoption in the middle market is accelerating but remains underserved. The PE ecosystem is concentrated (200 firms control most middle-market assets) and relationship-driven, enabling efficient go-to-market through network effects.TeamFounder Michael Cupps is described as an author, entrepreneur, and tech executive with 30+ years of experience delivering results in B2B tech leadership across sales and marketing, with multiple successful exits on leadership teams. He is focused on mid-market growth. No other team members were identified in the offering materials—the pitch references "the team that is being assembled" suggesting hiring is still underway.
FAQ
How much has Enterprise Diagnostics raised?
Enterprise Diagnostics has raised $58,379 of a $124,000 goal.
Where is Enterprise Diagnostics's campaign live?
The offering is live on Wefunder, an SEC-registered Reg CF intermediary.
What are the terms of Enterprise Diagnostics's raise?
SAFE, $10.8M cap, 20% discount.
When does Enterprise Diagnostics's offering close?
The stated close date is Apr 30, 2027.
